GE HealthCare Technologies

Money Moves

As of October 2026: Acquirer of Sofie Biosciences

GE HealthCare agreed to buy Sofie Biosciences, a U.S. manufacturer of radioactive imaging drugs, for $945 million in cash. The deal adds 15 manufacturing sites and 21 cyclotrons that produce F18-labeled tracers used in positron emission tomography (PET) scans.

Updated Oct 9

Money Moves

As of May 2026: Acquirer — integrating Intelerad to build cloud-first imaging platform

GE HealthCare has spent more than $2.5 billion on imaging software acquisitions in the three years since becoming an independent company — and the largest piece just fell into place. On March 18, the company completed its $2.3 billion purchase of Intelerad, a Montreal-based firm whose cloud software manages roughly 80 billion medical images across 2,500 healthcare organizations. Intelerad's strength in outpatient clinics and ambulatory care fills a gap in GE HealthCare's portfolio, which has historically centered on hospital-based imaging hardware like MRI and CT scanners.

Updated May 30